Loading
A phase 2 trial of Temoporfin in Nasopharyngeal carcinoma, run by Ministry of Health, Malaysia, with a status the registry has not verified recently.
Foscan®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma is a phase 2 interventional study registered as NCT01086488 by Ministry of Health, Malaysia, with 66 participants planned, started 2009-01 and due to reach its primary completion in 2011-09. Interventions recorded: FOSCAN. Conditions recorded: Nasopharyngeal Carcinoma.
Linked to the drug Temoporfin because the registry names it among its interventions and Nasopharyngeal carcinoma among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Temoporfin and the tag pipeline.
Shares Temoporfin and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Nasopharyngeal carcinoma and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Recurrent and metastatic nasopharyngeal carcinoma, Nasopharyngeal carcinoma and the tag pipeline.
Shares Nasopharyngeal carcinoma and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/